Editorial

A Full-Spectrum Cannabis Extract Tests the Botanical Drug Pathway

Roger Luo1
  1. 1 American Botanical Drug Association

How to Cite

1.
Luo R. A Full-Spectrum Cannabis Extract Tests the Botanical Drug Pathway. Botanical Drugs [Internet]. 2026 Jun. 6 [cited 2026 Jul. 12];1:75-6. Available from: https://botanicaldrugs.org/index.php/pub/article/view/18
Endnote/Zotero/Mendeley (RIS) BibTeX

References

  1. Karst M, Meissner W, Sator S, Keßler J, Schoder V, Häuser W. Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized, placebo-controlled trial. Nat Med. 2025;31(12):4189–4196. ClinicalTrials.gov: NCT04940741. https://doi.org/10.1038/s41591-025-03977-0
  2. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Botanical Drug Development: Guidance for Industry. December 2016.
  3. VERTANICAL. FDA grants Breakthrough Therapy Designation to VERTANICAL’s VER-01 for chronic low back pain [press release]. PR Newswire; 18 May 2026.
  4. Luo R. CMC challenges and solutions in botanical IND and NDA development: lessons learned from four approved botanical drugs. Botanical Drugs. 2026;1:02. https://doi.org/10.65239/botanicaldrugs.2026.02